GLS and non-small cell lung carcinoma: In ANGPTL4‐overexpressing cells, the regulatory effect on glutamine metabolism and fatty acid metabolites disappeared following treatment with both CPT1 and GLS inhibitors, and there was no significant difference in the proliferative activity between ANGPTL4‐overexpressing cells and normal NSCLC cells.